Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Ibrahim

Showing results (111-120 of 223) with videos related to

Pageof 23
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
Scientific Reports|March 4, 2021
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancerAlessandro De Vita, Chiara Liverani, Roberto Molinaro, et al.
Oncotarget|January 7, 2017
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathwayDino Amadori, Patrizia Serra, Nestory Masalu, et al.
Biomedicines|February 25, 2022
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational EvidencesAlessandro De Vita, Silvia Vanni, Giacomo Miserocchi, et al.
Nature Cell Biology|February 12, 2013
miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasisYun Zhang, Pengyuan Yang, Tao Sun, et al.
Journal of Bone Oncology|February 12, 2026
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational studyPaolo Taurisano, Ester Cornacchia, Maria Fara De Caro, et al.
Journal of Clinical Medicine|May 9, 2020
Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter AnalysisGiuseppe Lamberti, Maria Pia Brizzi, Sara Pusceddu, et al.
Future Oncology (London, England)|December 20, 2014
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case reportAlberto Bongiovanni, Marianna Ricci, Nada Riva, et al.
Oncology Letters|October 5, 2016
RANKL: A promising circulating marker for bone metastasis responseToni Ibrahim, Marianna Ricci, Emanuela Scarpi, et al.
International Journal of Clinical Practice|August 14, 2019
Clinical role of filgrastim in the management of patients at risk of prolonged severe neutropenia: An evidence-based reviewAlberto Bongiovanni, Federica Recine, Valentina Fausti, et al.
Pageof 23

Showing results (111-120 of 223) with videos related to

Sort By:
Pageof 23
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
Scientific Reports|March 4, 2021
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancerAlessandro De Vita, Chiara Liverani, Roberto Molinaro, et al.
Oncotarget|January 7, 2017
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathwayDino Amadori, Patrizia Serra, Nestory Masalu, et al.
Biomedicines|February 25, 2022
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational EvidencesAlessandro De Vita, Silvia Vanni, Giacomo Miserocchi, et al.
Nature Cell Biology|February 12, 2013
miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasisYun Zhang, Pengyuan Yang, Tao Sun, et al.
Journal of Bone Oncology|February 12, 2026
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational studyPaolo Taurisano, Ester Cornacchia, Maria Fara De Caro, et al.
Journal of Clinical Medicine|May 9, 2020
Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter AnalysisGiuseppe Lamberti, Maria Pia Brizzi, Sara Pusceddu, et al.
Future Oncology (London, England)|December 20, 2014
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case reportAlberto Bongiovanni, Marianna Ricci, Nada Riva, et al.
Oncology Letters|October 5, 2016
RANKL: A promising circulating marker for bone metastasis responseToni Ibrahim, Marianna Ricci, Emanuela Scarpi, et al.
International Journal of Clinical Practice|August 14, 2019
Clinical role of filgrastim in the management of patients at risk of prolonged severe neutropenia: An evidence-based reviewAlberto Bongiovanni, Federica Recine, Valentina Fausti, et al.
Pageof 23